Global Interbody Fusion Cage Market Overview:
An interbody fusion cage is an implantable medical device utilized to maintain the normal height of the spine. Interbody fusion cages are interleaved between the spinal cords when the space between the discs gets diverted. Materials used for manufacturing interbody fusion cages are titanium, carbon fiber, or allograft femur. Interbody fusion cages are either square or cylindrical-shaped and are mostly threaded. The incidence of lumbar degenerative diseases such as spinal stenosis and degenerative spondylolisthesis is increasing due to the aging population, and this has projected the growth of the global interbody fusion cage market in the forecast period. According to AMA, the Global Interbody Fusion Cage market is expected to see growth rate of 3.62%
Growth Drivers
- Increasing in Geriatric Population and Rise in Incidences of Spinal Injuries and Sports Injuries across the Globe
- An upsurge in Demand for Interbody Fusion Cage Surgeries due to Advantages that allow the Surgeon to Directly Decompress Nerves and Reconstruct the Spine
Market Trends
- Growing Demand Due to Launch of Novel Interbody Fusion Cages with new Compatible Materials
Roadblocks
- High Costs Associated with Spinal Fusion Surgeries
Opportunities
- Rising Consumer Awareness Regarding Spinal Fusion treatment in both Developed and Developing Countries
Challenges
- Lack of Trained Professionals as well as Stringent Rules & Regulations to Use
Competitive Landscape:
Some of the key players profiled in the report are Aurora Spine, Inc. (United States), B. Braun Melsungen AG (Germany), Benvenue Medical, Inc. (United States), Ulrich Medicals USA (United States), Prodorth (Turkey), Johnson & Johnson (United States), Orthofix International, N.V. (United States), Medtronic, plc (United States), Zimmer Biomet, Inc. (United States), NuVasive, Inc. (United States) and Spinal Elements, Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like Precision Spine, Inc. (United States), Medacta International (Switzerland), Biomet USA (United States), Globus Medical USA (United States) and Spineart Sa (Switzerland). Analyst at AMA Research see United States Players to retain maximum share of Global Interbody Fusion Cage market by 2026. Considering Market by Surgery Type, the sub-segment i.e. Anterior Surgery will boost the Interbody Fusion Cage market. Considering Market by End User, the sub-segment i.e. Hospital will boost the Interbody Fusion Cage market.
Latest Market Insights:
On 2nd November 2020, Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, has announced that it has commercially launched its proprietary SOLOTM ALIF Stand-Alone Cage system to its innovative suite of MIS products used in spinal surgery.
On 30th October 2020, Spinal Elements has announced the newest introduction in its MIS Ultra suite of products with the full release of the Lucent XP Wide expandable interbody device. This addition to Spinal Elements’ expandable interbody portfolio offers surgeons a wider footprint option than previously available and is designed with an anatomically oriented lordotic angle.
What Can be Explored with the Interbody Fusion Cage Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Interbody Fusion Cage Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Interbody Fusion Cage
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Interbody Fusion Cage market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Interbody Fusion Cage market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Interbody Fusion Cage Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.